- Tytuł:
- Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
- Autorzy:
- Źródło:
- In eBioMedicine December 2023 98
Czasopismo naukowe